Skip to main content
Marker Therapeutics, Inc. logo

Marker Therapeutics, Inc. — Investor Relations & Filings

Ticker · MRKR ISIN · US57055L1070 US Manufacturing
Open in API
Filings indexed 899 across all filing types
Latest filing 2001-05-15 Interim / Quarterly Rep…
Country US United States of America
Listing US MRKR

About Marker Therapeutics, Inc.

https://markertherapeutics.com/

Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company developing next-generation T cell-based immunotherapies for hematologic malignancies and solid tumors. The company's core technology is its Multi-Antigen Recognizing (MAR) T cell platform, which utilizes natural, non-genetically modified T cells to recognize and kill heterogeneous tumors. This approach is designed to provide durable anti-tumor responses with a favorable safety profile. Its lead product candidate, MT-601, recognizes six tumor-specific antigens and is being evaluated in a Phase 1 study for patients with lymphoma who have relapsed or are ineligible for anti-CD19 CAR-T cell therapy. The technology was originally developed at Baylor College of Medicine.

Recent filings

Filing Released Lang Actions
FORM 10-QSB - FIRST QUARTER 2001
Interim / Quarterly Report Classification · 100% confidence The document is a Form 10-QSB filed with the U.S. Securities and Exchange Commission for the quarterly period ended March 31, 2001. It contains unaudited interim consolidated financial statements, including balance sheets, statements of operations, cash flows, notes to the financial statements, and management's discussion and analysis. The document explicitly states it is an interim report and includes detailed financial data and analysis for a period shorter than a full fiscal year. Therefore, it fits the definition of an Interim / Quarterly Report (IR). The document length is substantial (15,000 characters), and it is not merely an announcement or certification. Hence, the correct classification is IR with high confidence.
2001-05-15 English
SCHEDULE 13D
Major Shareholding Notification
2001-05-14 English
SCHEDULE 13D
Major Shareholding Notification
2001-05-14 English
DEFS14A
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled 'PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934' and is a Definitive Proxy Statement filed by the registrant Eduverse.Com. It includes detailed information about a Special Meeting of Shareholders, including the agenda items such as approval of a sale of assets, reverse stock split, election of directors, and ratification of auditors. It also contains voting procedures, security ownership details, and executive compensation information. The content is consistent with materials sent to shareholders to solicit votes for corporate actions, which aligns with the definition of Proxy Solicitation & Information Statement (PSI). The document is lengthy (15,000 characters) and contains substantive information, not just an announcement or a brief summary. Therefore, the correct classification is PSI with high confidence.
2001-05-08 English
PRER14A
Proxy Solicitation & Information Statement Classification · 95% confidence The document is titled 'AMENDMENT NO. 1 TO PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934' and contains detailed information about a special meeting of shareholders, including proposals to be voted on, voting procedures, and shareholder information. It discusses solicitation of proxies, election of directors, approval of asset sales, and amendments to articles of incorporation. The content is consistent with proxy solicitation materials rather than the actual proxy statement or voting results. The document is an amendment to a proxy statement, which falls under the category of Proxy Solicitation & Information Statement (PSI). It is not an announcement of voting results (DVA), nor a full annual report or financial report. Therefore, the correct classification is PSI with high confidence.
2001-05-03 English
PRELIMINARY PROXY STATEMENT - SPECIAL MEETING
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled 'PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934' and contains detailed information about a special meeting of shareholders, including proposals to be voted on, voting procedures, security ownership, and executive compensation. It is clearly a proxy solicitation document intended to inform shareholders and solicit their votes for the special meeting. The content includes election of directors, approval of asset sale, reverse stock split, and ratification of auditors, which are typical proxy statement topics. There is no indication that this is an annual report, earnings release, or other financial report. The document is not a mere announcement of a report but the actual proxy statement itself. Therefore, the correct classification is Proxy Solicitation & Information Statement (PSI).
2001-04-27 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.